Bioengineered amyloid peptide for rapid screening of inhibitors against main protease of SARS-CoV-2
Description
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has evoked a worldwide pandemic. As the emergence of variants has hampered the neutralization capacity of currently available vaccines
